Table 1. Analysis of the association between lncRNA AC079630.4 expression and clinicopathological features of lung cancer based on dataset GSE31210.
| Variables | Low expression (n=113) | High expression (n=113) | P value |
| Age (years) | 56.0 ± 0.66 | 59.2 ± 0.73 | 0.457 |
| Gender | |||
| Male | 58 (51.3%) | 47 (41.6%) | 0.142 |
| Female | 55 (48.7%) | 66 (58.4%) | |
| Smoking | |||
| Yes | 61 (54.0%) | 50 (44.2%) | 0.143 |
| No | 52 (46.0%) | 63 (55.8%) | |
| TNM stage | |||
| Ia | 41 (36.3%) | 73 (64.6%) | <0.001 |
| Ib | 27 (23.9%) | 27 (23.9%) | |
| II | 45 (39.8%) | 13 (11.5%) | |
| ALK fusion | |||
| Yes | 7 (6.2%) | 4 (3.5%) | 0.354 |
| No | 106 (93.8%) | 109 (96.5%) | |
| EGFR mutation | |||
| Yes | 61 (54.0%) | 38 (33.6%) | 0.002 |
| No | 52 (46.0%) | 75 (66.4%) | |
| KRAS mutation | |||
| Yes | 13 (11.5%) | 7 (7.1%) | 0.160 |
| No | 100 (88.5%) | 106 (92.9%) | |
| MYC expression | |||
| High | 8 (7.1%) | 9 (8.0%) | 0.801 |
| Low | 104 (92.9%) | 103 (92.0%) |